[1] Niccoli G, Montone RA, Ferrante G,et al. The evolving role of inflammatory biomarkers in risk assessment after stent implantation [J]. J Am CollCardiol, 2010,56(22): 1783-1793. [2] Walter DH, Fichtlscherer S, Sellwig M,et al. Preproce-dural C- reactive protein levels and cardiovascular events after coronary stent implantation [J]. J Am CollCardiol, 2001,37(3):839-846. [3] Kosmidou I, Redfors B, Chen S,et al. C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial [J]. Am Heart J,2019 (210):49-57. [4] Shitara J, Ogita M, Wada H, et al. Clinical impact of high- sensitivity C- reactive protein during follow- up on long-term adverse clinical outcomes in patients with coro-nary artery disease treated with percutaneous coronary in-tervention [J]. J Cardiol, 2019,73(1):45-50. [5] Kangasniemi OP, Biancari F, Luukkonen J,etal. Preoper-ative C- reactive protein is predictive of long- term out-come after coronary artery bypass surgery [J]. Eur J Car-diothoracSurg,2006,29(6):983-985. [6] Hedman A, Larsson PT, Alam M,et al. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events [J]. Int J Cardiol, 2007,120(1):108-114. [7] Kaptoge S, Seshasai S, Gao P,et al. Inflammatory cyto-kines and risk of coronary heart disease: new prospective study and updated meta-analysis [J]. Eur Heart J, 2014,35 (9):578-589. [8] Ridker PM, Everett BM, Thuren T,etal. Antiinflammato-ry Therapy with Canakinumab for Atherosclerotic Disease [J]. N Engl J Med, 2017,377(12):1119-1131. [9] Li SM, Li JG, Xu H. A New Perspective for Chinese Medicine Intervention for Coronary Artery Disease: Target-ing Inflammation [J]. Chin J Integr Med, 2018,25(1):3-8. [10] Palmerini T, Marzocchi A, Marrozzini C,et al. Preopera-tive C-reactive protein levels predict 9-month mortality af-ter coronary artery bypass grafting surgery for the treat-ment of left main coronary artery stenosis [J]. Eur J Car-diothoracic Surg,2007,31(4):685-690. [11] Cappabianca G, Paparella D, Visicchio G,et al.Preopera-tive C- reactive protein predicts mid- term outcome after cardiac surgery [J]. Ann ThoracSurg, 2006,82(6):2170-2178. [12] Weymann A, Popov AF, Sabashnikov A,et al. Baseline and postoperative levels of C-reactive protein and interleu-kins as inflammatory predictors of atrial fibrillation follow-ing cardiac surgery: a systematic review and meta-analysis [J]. Kardiol Pol, 2018,76(2):440-451. [13] Johari MA, Azizinejad S. AzizinejadSaiedStudy of High Sensitive C-Reactive Protein (HS-CRP) After Cardiac Re-habilitation Program in Patients Undergoing Isolated CABG [J]. Int J Biomed Sci,2016,12(4):143-148. [14] Wang W, Li B, Wang Y,et al. Experience of the man-agement of coronary artery bypass graft only on moderate ischemic mitral regurgitation: A single-center retrospective study [J]. Medicine (Baltimore),2019,98(17):e14969-e14969. [15] Arora Y, Singh RS, Sampath S,etal. Impact of hibernat-ing and viable myocardium on improvement in perfusion and left ventricular ejection fraction after coronary artery bypass graft [J]. Nucl Med Commun,2019,40(4):325-332.